Mathematical modelling of tumor growth is one of the most useful and inexpensive approaches to determine and predict the stage, size and progression of tumors in realistic geometries. Moreover, these models has been used to get an insight into cancer growth and invasion and in the analysis of tumor size and geometry for applications in cancer treatment and surgical planning. The present revision attempts to present a general perspective of the use of models based on reaction-diffusion equations not only for the description of tumor growth in gliomas, addressing for processes such as tumor heterogeneity, hypoxia, dormancy and necrosis, but also its potential use as a tool in designing optimized and patient specific therapies.
with most of the gliomas, its growth is so fast and extensive that patients do not exhibit any symptoms imposing serious limitations for treatment. Depending on its grade, gliomas exhibit internal necrotic regions and a periphery of active tumor cells that invades the surrounding tissue. In the case of glioblastomas or high grade gliomas, images obtained by contrast enhanced CT or MRI commonly resembles the tumor growth as a kind of explosion, i.e., a fast growing front wave of very active tumor cells that expands and leaves behind hypoxic, hypoglycemic or necrotic tissues. This type of growth can be described by reaction-diffusion equations or ballistic growth models, or proliferative-invasive models in the biological context. In the following sections several reaction-diffusion models will be discussed, how the effect of oxygenation and nutrient concentration has been addressed to account for cell hypoxia, tumor dormancy and necrosis, how model parameters are extracted from different medical imaging modalities and how all this knowledge has led to the proposal of working models to simulate and optimize different therapies.
Reaction-Diffusion Basic Model.
The first attempts to model glioma tumor growth by means of a reaction-diffusion mathematical model [1] were performed by Cruywagen et al. [2] , Tracqui et al. [3] and Woodward et al. [4] in order to account for the effect of therapies on glioma growth and later by Burgess et al. [5] to emphasize the importance of diffusion on glioma growth. The model is described by a partial differential equation [1] , = −∇ • ⃗ + ( , ) − ( , ) (1) where is the tumor cell concentration, ⃗ is the tumor cellular flux, ( , ) is a term that accounts for cellular proliferation and ( , ) represents the contribution of treatment. Assuming that the cellular flux obeys Fick's law, ⃗ = − ∇ (2) and the proliferation term is set to produce an exponential growth, then equation where is a diffusion coefficient that accounts for tumor invasiveness and is the tumor cell proliferation rate. The solution of equation (3) is restricted by the boundary condition that the flux of cells outside the brain or into the ventricles is zero, that is,
where ⃗⃗ is a unitary vector normal to the cortical and ventricular surfaces.
Experiments performed on rats demonstrated that glioma cells disperse more effectively along white matter axon tracts [6] [7] [8] than along neuronal cell bodies in gray matter, which leads to a variation of equation (3), proposed by Swanson et al. [9, 10] , which includes the spatial dependence of the diffusion coefficient ,
To evaluate the differences between grey and white matter motilities, Swanson et al. [9, 10] used the Fisher approximation [1, 11] which stablishes that a travelling wave solution of equation (3) propagates with a terminal velocity given by,
Equation (6) allows for the estimation of the diffusion coefficient knowing the wave front propagation velocity and the proliferation rate, . Fisher's approximation has been used extensively for parameter extraction of gliomas by Mandonnet et al. [12] . Wave front velocities were obtained from the analysis of CT scans [2] [3] [4] [5] 12] and finally, assuming a proliferation rate = 0.012 −1 , the diffusion coefficients can be estimated [9, 10] [5] , The results of these simulations are shown in Figure 1 , where it can be appreciated that tumor
extension greatly exceeds what is detected by contrast enhanced CT [5] , depicted as thick black contours. Equation (5) predicts an exponential growth of tumor cell concentration, which at longer times achieves a value that is no longer realistic or sustainable at cellular level due to the scarcity of oxygen and nutrients.
This problem can be easily solved by assuming that there is a limit concentration,
, and the proliferative term in equation (5) is changed by a logistic or Verhulst growth model,
From now on, this model is called the Proliferative Invasive model or PI model and represents the starting point for the proposal of more realistic models.
Adding more reality to the model.
One of the advantages of equation (7) is that it is parametrized with few parameters which can be easily extracted from patient data, being the main difficulty the computational implementation to solve it on reliable virtual environments. Some additional considerations have to be done in order to obtain a glioma growth model that takes into account the anisotropy of the diffusion tensor, which is particularly relevant in brain tissue, the effect of mechanical deformations or mass effect and tumor heterogeneity.
a) Anisotropy of the Diffusion Tensor.
The diffusive term in equation (7) not only exhibits a spatial variation depending if brain tissue corresponds to either gray or white matter, but it has tensor properties as well, so gray matter is mostly isotropic while white matter is highly anisotropic, In the case of white matter, diffusion along the fiber axon tracts is Taking this fact into account, equation (7) can be rewritten as [19] [20] [21] ,
for highly anisotropic white matter, and in the case of gray matter which is nearly isotropic, i.e.,
which corresponds to the model described by equation (7) where only the spatial heterogeneity [9, 10] is considered. Simulations were performed by Jbabdi et al.
[21] using equation (8) and diffusion tensor MRI (DT-MRI) data [22] [23] [24] . Since DT-MRI only maps the diffusion of water molecules, and tumor cell diffusion along white matter axon tracts is likely to be more anisotropic [25, 26] , some assumptions were made to determine tumor cell diffusion in equation (8) starting from DT-MRI data, for instance, a scaling factor that preserves the axon tract direction but changes the diffusion tensor magnitude and anisotropy. The diffusion tensor can be transformed to its diagonal form [27] and can be written as, 
with + + = 1. Depending on the eigenvalues , the tensor is linear, = 1, planar, = 1, or spherical = 1, the isotropic case, i.e., gray matter. The scaled tensor can be defined as [21] ,
where,
For the simulations, = 10 was used [21] . A more general approach, assuming a proportionality between tumor cell diffusion anisotropy and diffusion tensor fractional anisotropy was proposed by Painter et al. [28] 
With, (̃), the fractional anisotropy of the diffusion tensor [22] [23] [24] 27] , defined as,
where are the diffusion tensor eigenvalues Results of simulations carried on real Diffusion Tensor Imaging or DTI are shown in Figure 2 , showing a strong dependence on the anisotropy enhancement parameter, . To evaluate the correspondence of actual tumor DT images with the simulations, first Moyasebi et al. [29] and later, Swan et al. [30] , used the Jaccard index which is a measurement of similarity between two finite data sets, i.e. simulated tumor growth and actual tumor DTI, and defined as,
with, and , the simulated tumor and the actual tumor DTI, respectively.
The Jaccard index was used to optimize tumor growth parameters such as the initial starting point, proliferation rates and anisotropy enhancement parameter [30] . The initial starting point was determined by computing the Jaccard index for simulations starting at different points and selecting the one with the maximum value of the index. Similarly, the tumor growth time was determined by computing the Jaccard index along the time evolution in a simulation, as shown in Figure 3 .
The first attempt to include mechanical deformations to the glioma growth model were introduced by Clatz et al [19, 20, 31] . They used rheological brain properties [32] [33] [34] 
where ̃ is the internal stress tensor and ⃗ is the external force. Since the growing process is very slow, it can also be assumed that there are linear relationships for the constitutive equation and the strain computation,
where ̃ is the elasticity tensor, ̃ is the linearized Lagrange strain tensor and ⃗⃗ is the tissue displacement. Following Wasserman et al. [35] , they proposed a modified equilibrium equation to take into account the mechanical impact of the tumor growth (mass effect) on the surrounding tissue, with a term proportional to the tumor concentration, ,
Some of the results are shown in Figure 4 , where it can be appreciated that the higher the tumor cell concentration is, shown in Figure 4a , the stronger is the mass effect, which corresponds to high tissue displacements or deformations, as shown in Figure 4b . More generally, Hogea et al. [36] [37] [38] proposed a general mass balance equation for the tumor growth,
where the tumor cell concentration has been normalized to the maximum and an advection term has been added which includes a drift velocity, ⃗ which depends on tumor specific mechanisms such as, for example, chemotaxis [36] .
The stress tensor is defined in a similar way to references [19, 20, 31] , as follows,
where and are Lame`s coefficients, related to Young`s modulus and
Poisson's ratio . The equilibrium equation (20) is modified to,
where the proportionality factor, ( , ⃗), is positive and as proposed in references [36] [37] [38] , can be parametrized as,
with ⃗ = ( 1 , 2 , ). Equation (24) is a monotonically increasing function in the concentration range 0 < ≤ 1 with its maximum at = 1. To complement equations (21) and (23), the following set of equations have to be added,
where ⃗⃗⃗ stands for ( , ,̃). Equations (21), (23), (25) and (26) were used by Gooya et al. [39] to perform atlas registration of simulated gliomas with patient images, in order to evaluate tumor location, mass effect and degree of infiltration, with results shown in Figure 5 .
c) Tumor Heterogeneity, Hypoxia, Necrosis and Angiogenesis.
The World Health Organization (WHO) grading scheme for gliomas takes into account variations in tumor cellularity, mitoses and vascular proliferation. In particular, the characteristic vascularity of high grade gliomas, such as glioblastomas, and the relation to glioma growth to neo vascularity or angiogenesis is a key feature in the modeling of glioma growth [40] [41] [42] . Swanson et al. [43] proposed a model that included angiogenesis together with hypoxia and necrosis in order to quantify the role of angiogenesis in the malignant progression of gliomas. The starting equation is given by equation (7) but with certain modifications,
and ℎ, and are the hypoxic, vascular and necrotic cell concentrations, respectively. The first two terms in equation (27) account for the dispersion and proliferation of normoxic glioma cells, the third corresponds to the conversion of hypoxic to normoxic glioma cells, the fourth to the conversion of normoxic to hypoxic glioma cells and the fifth to the conversion of normoxic to necrotic glioma cells, that depends on necrotic cell concentration through a factor [44] . Similar equations can be written for ℎ, and , the hypoxic, necrotic and vascular, respectively,
where the first term is the dispersal of vasculature, i.e. endothelial cells, characterized by a diffusion coefficient [45] , the second corresponds to the vasculature proliferation that depends on the concentration of angiogenic factors,
, with a maximal proliferation rate [46] , and the third term corresponds to the conversion of vasculature to necrotic tissue. Finally the equation for the angiogenic factors concentration is,
Which includes the diffusion of the angiogenic factors with [47] , the production of these factors by normoxic cells [48] , at a rate and by hypoxic cells (VGEF), at a rate ℎ [49] and its decay with rate [50] . The last two terms in equation (33) correspond to the net consumption of angiogenic factors by the vasculature. Main results are shown in Figure 6 . Notice that as tumor grading increases there is an enhancement of normoxic and hypoxic tumor cell concentrations, as well as endothelial cell and VGEF concentrations close to the tumor interface, particularly for Grade IV gliomas, Figure 6a .
Some variations to the previous scheme were proposed by Papadogiorgaki et al.
[51] by assuming a multi-compartmental model of coupled reaction diffusion equations, each one related to compartments that are spatially distributed along the tumor from its periphery to its inner necrotic core as shown in Figure 7 . Each compartment is characterized by glioma cell viability and phenotype and, starting at the tumor outer interface, there is a proliferative compartment, followed by a hypoxic, hypoglycemic and necrotic compartments, all of them embedded in the extracellular matrix or ECM, which supplies for oxygen and glucose to the tumor compartments and is destroyed by matrix-degradative enzymes or MDEs [52] which are secreted by proliferative and hypoxic glioma cells. Increased glucose consumption by cancer cells, known as the Warburg effect [53] , with independence on oxygen levels justifies the inclusion of the hypoglycemic compartment in a separate way to the hypoxic compartment [52] [53] [54] [55] . The diffusion equations for each compartment are,
where ̃ is a modified proliferation rate that depends on oxygen and glucose concentrations [51] , ℎ , are the conversion rates from hypoxic and hypoglycemic to proliferative, respectively, ℎ , , the conversion rates from proliferative to hypoxic or hypoglycemic, respectively, and ℎ , are variables that depend on the oxygen and glucose concentration thresholds, such that they take the value 0 if the concentration is above the threshold and 1 otherwise, finally, as in equation (27) , there is a term to account for conversion to the necrotic compartment and is similarly defined as in equation (28),
Similarly, for the hypoxic compartment,
The last three terms in equation (36) correspond to conversion to the necrotic compartment, depending on oxygen and glucose threshold concentrations [51] though the coefficients ℎ and ℎ , as,
For the hypoglycemic compartment, 
As it is readily seen, models given by [43, 51] 
where is a threshold for the cellular concentration and is the rate at which tumor cell concentration decay exponentially after this threshold is exceeded.
Both quantities , ∈ (0,1) and for the simulations the following values were used = 0.85, = 0.90 for best results fitted with patient data [61] . Part of the results are shown in Figure 10 .
Simulation of Therapy.
Treatment of gliomas is commonly initiated by tumor resection, followed by radiotherapy and chemotherapy either separately or in combination. The reaction-diffusion model was used for tumor resection therapy [4, 62, 63] , chemotherapy [3, 64, 65] and radiation therapy [59, [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] . Commonly, the effect of therapy is included in the differential equation as,
= ∇ • (̃∇ ) − ∇ • ( ⃗) + ( ) − ( , )
where ( , ) takes into account terms that describe the application of therapy or a combination of therapies and exhibits an explicit time dependence according to the therapeutic protocol. The tumor growth model is considered in a general way including heterogeneous and anisotropic diffusion and advection terms combined with a proliferative term ( ) which can be either exponential, logistic or Gompertz.
a) Tumor resection therapy.
Tumor resection therapy was simulated as soon as the reaction diffusion model for glioma growth was proposed [4] .To account for this kind of therapy within the context of the reaction diffusion equation, tumor growth evolution is given by equation (49) and separated in two stages: Before tumor resection, which depends on tumor initial localization as an initial condition, and after tumor resection, assuming that the differential equation is subjected to the following condition [62] ,
where ( 
where ( ) is a time dependent function defined by,
where is the strength of the action of the therapy drugs upon tumor cells and the sets { } and { } represent the collection of time intervals for which the drugs are administered (on) or not (off), respectively. Typically, chemotherapy is applied in treatment cycles, each one consists of the administration of drugs for a period of time ℎ followed by a waiting period , meaning that the time dependence of ( ) is an alternating function, periodic in most of the protocols used in chemotherapy, during the entire treatment time. The relevant parameter to determine the efficacy of the therapy is the ratio = / [64] , which is a dimensionless parameter that compares the death rate caused by the drug to the proliferation rate, i.e. if > 1, therapy effectively provides tumor control, see Figure 12a . In the case of heterogeneous drug delivery, equation (52) Radiation therapy is usually modelled by the linear-quadratic or LQ radiobiological model [76, 77] , which assumes that the survival fraction of cells subjected to a total dose is given by,
where and are parameters that characterize the response of tissue to ionizing radiation, which is determined by the damage that can be imparted to the DNA structure by the radiation. The damage depends on the Linear Energy Transfer or LET [76, 77] of the ionizing particle (charged particles, neutrons or photons) and on which phase of the cell cycle, G2 or mitosis is the cell present. In order to avoid toxic effects of the radiation to normal tissue, radiotherapy is usually administered in fractions, and a biologically effective dose can be defined [77] ,
with , the number of fractions and , the dose applied per fraction. In this case, the survival probability after the fractionated treatment is,
Different schemes can be used for radiotherapy fractionation, ( ), but typically, a fractionation scheme comprises 6 weeks of treatment, 5 days a week with weekend interruptions. Also, radiotherapy is a localized therapy, so the fraction dose is position dependent and it has to be taken into account during therapy (61) where it has been emphasized the explicit time dependence of the fractionation scheme, ( ), and ( ( )) is defined as,
and ( , , ( )) is the survival probability after one fraction dose,
There are two problems in relation to equation (61) . The first one is related to the tumor cell concentration dependence of the radiation therapy term, i.e., a logistic one, which certainly assumes some negative "proliferation rate" given by equation (62) , and for > 1 , introduces a positive contribution to tumor cell concentration, what is nonsense, so the radiation therapy term must be exponential with a negative cell death rate, − . Nevertheless, equation (61) will reproduce qualitatively the typical behavior of the tumor size evolution, as shown in Figure 13 . Additionally, equation (62) represents the cell death fraction due to radiation therapy and being a probability, it is a dimensionless quantity, so in order to keep all the terms in equation (61) with the same units, Rockne et al. [78] proposed that since fractionated radiotherapy is applied on a daily basis, equation (62) represents the probability of cell death during a time interval of 1 day and can be considered as a probability rate. Although this argument seems to be valid, Borasi et al. [73] developed a straightforward method to evaluate the cell death rate due to ionizing radiation, starting from the linear-quadratic model. If the radiation is applied at a constant dose rate, ̇, during a time , then according to the L-Q model, the cell concentration is,
where ( ) is the administered dose at time , then,
Taking into account that the irradiation time, ∆ , is very small (of the order of minutes) compared to the time interval between fractions (one day), equation (65) can be replaced by its mean value over the irradiation time interval, ∆ , so equation (61) must be replaced by [73] ,
Equation (66) is unit consistent and has the correct dependence of the therapy term on tumor cell concentration. Nevertheless, if the therapy term is considered alone, equation (66) does not recover the survival probability of the L-Q model, equation (64) , so it must be replaced for one that includes the complete therapy term as given by equation (65),
Due to the fact that ̃ and are very small quantities, the temporal evolution of the tumor cell concentration imposed by the reaction diffusion terms during the time interval of radiation therapy can be considered as negligible, i.e. a suitable time interval for numerical integration of equation (67) is 1 day. Integration of equation (67) in a time interval very small compared to 1 day yields the correct survival probability of the L-Q model. This result allows for decoupling proliferation invasion from radiotherapy terms in equation (67) so at the end of 1 day of time evolution under radiotherapy conditions, tumor cell concentration is,
with , the tumor cell concentration obtained from the proliferation invasion model. This approach has been used by Rojas et al. [59] and Unkelbach et al. [79, 80] for high grade gliomas and by Henares-Molina et al. [81] for low grade gliomas.
The other aspect that has to be considered simulating radiation therapy is that it is a localized therapy and tumor delineation is very important for the therapy to be effective. Using the reaction diffusion model for glioma growth, Konukoglu et al. [82] demonstrated that the tumor cell concentration falls approximately in an exponential way depending on the distance, | ⃗|, measured from the detectable tumor interface, i.e., defined by contrast enhanced MRI,
where is defined as the infiltration length and depends on the particular tissue, grey or white matter. It is related to the model parameters by, = √ (70) Clearly, the infiltration length for white matter is bigger that the infiltration length for grey matter, ~√ / . Equation (70) allows for an improved tumor delineation using the infiltration length or multiples of it to establish a safety margin for the prescribed dose to be applied [80] . The estimation of subthreshold tumor based on the PI-DTI growth model has been proposed by Hathout et al.
[83] as a tool for tumor delineation in radiation therapy planning. Unkelbach et al.
[79] developed a treatment planning method that determines the cumulative dose , distributed in fractions, which minimizes the survival probability within the tumor lesion, expressed as,
where = / , ̅ = (1 + ), the effective radiosensitivity, and is the average prescription dose over the tumor lesion. The optimization problem is formulated as follows [79] . The integral cell survival,
is minimized subject to the condition,
The sums are performed over all the voxels within the tumor lesion volume, .
The optimal solution is obtained by looking at the stationary points of the Lagrange function [79] , (74) where is the Lagrange multiplier and is given by [79] ,
Results imposing the dose restrictions, given by equation (73) , and the infiltration length dependence, given by equation (69) , are shown in Figure 14 . This approach has recently used by Lê et al. to establish a personalized treatment planning [84] . These results are applicable to define an optimal treatment planning and can be modified depending on the treatment specifics, i.e., single fraction or multifractioned treatment, IMRT or VMAT, and it minimizes the survival probability of the tumor lesion. In order to maximize the patient's survival probability, it is necessary to simulate a collection of virtual patients, all of them prepared with parameters derived from the actual patient, and subject them to the selected therapy. The patient's survival probability is then obtained by a
Kaplan-Meier analysis [85] over the simulated course of the therapy. Rojas et al. [59, 86] developed a method to estimate the effect of therapy over the patient´s survival probability, using the multi compartmental tumor growth model described in [58, 59] and assuming additional transition rules imposed by the therapy, as shown in Table 2 . Radiotherapy was considered as in equation (68), with a survival probability ( , , ) according to Table 3 , depending if the tissue is normoxic, hypoxic or hypoglycemic. Results are shown in Figure 15 .
Conclusions.
It Black contour denotes the detection threshold by enhanced CT. Simulation elapsed time for diagnosis is 158 days and for death, 256 days. Adapted from [13, 14] . Adapted from [43] . after resection: Actual patients subjected to gross total resection (GTR, asterisks), simulated patients subjected biopsy and no resection (BX/STR squares), simulated patients total resection of a volume defined by contrast enhanced MRI, with radius 1 (GTR, circles) and simulated patients with total resection for 1.25 1 . Adapted from [62, 63] . 
